FDA Panel to Decide Fate of Egrifta [tesamorelin], a Promising Gut Fat Fighter - by David Evans

POZ.com - Web Exclusives : FDA Panel to Decide Fate of Egrifta, a Promising Gut Fat Fighter - by David Evans: "“People’s lives and their quality of life are at stake here. It’s hard to quantify, but quality of life is so very, very important to living and thriving with HIV,” says Jeff Berry, who will be testifying at the FDA hearing on behalf of the AIDS Treatment Activists Coalition (ATAC)."